About Us


 Crypto-ppars logo

 

 

 

 

 

 

 

 

PPARs Century Sdn Bhd (formerly known as Crypto PPARs Sdn Bhd) was recently founded in April, 2010 as the OFFICIAL marketing arms of International Cryptomonadales Biotechnology Co.,Ltd (ICBC) Taiwan with the ultimate founding objectives in providing the general publics the AFFORDABILITY access into the latest healthcare product currently available ONLY in technologically advance countries like the United States, Britain & Germany; especially in the arena of GENETICS Technology.


In PPARs Century, we believed that the general publics has the rights to gain access into all this products and we are COMMITTED to ensures that we provide the best healthcare products available at an AFFORDABLE price for everyone to enjoy great health and wellness.

 

 

 

  

Our Vision

Our vision is to "Spread the TRUTH; CURE to ROOTS" of sickness and diseases suffered by mankind.This is because; in Crypto PPARs; we BELIEVED that man SHALL DIE of OLD AGE and NOT because of sickness and diseases. 

 

 

 

Our Mission

Our vision is to "Share & Educate the Importance of Genetic Repair to Mankind" as in line with the ultimate objective from the world Human Genome Project (HGP) as being promoted by the U.S National Health Research Institute.

  

 

 

  

  

Our Founding Father

 

 

 

Prof. Dr. Wang Shun Te, the founder of International Cryptomonadales Biotechnology Co., Ltd (ICBC) Taiwan, with experiences of more than thirty years in algae researches has gone through numerous hardships and efforts since 1990 in order to nurture the most purified and the most precious Cryptomonadales. After that, various Cryptomonadales products that benefit the human health and have slimming features are developed one after another. The Cryptomo series and CRYPTO- PPARs series are developed after that. These products are nurtured and refined in compliance with a pure and natural approach completely so as to fully develop the rich and balanced nutritious ingredients contained therein without any side effect and can be taken for a long term.

 

 

Our Medical Consultant

 

 

Prof. Dr. Su, Ih-Jen                                                                    

Distinguished Investigator and Director
Division of Infectious Diseases

EDUCATION

Ph.D., Pathology, Institute of Pathology, National Taiwan University, 1988.
M.D., Medicine, National Taiwan University Medical College, 1976.

PROFESSIONAL EXPERIENCES

  • Distinguished Investigator and Director, Division of Clinical Research, National Health Research Institutes, Taiwan
  • Professor, Institute of Clinical Medicine, National Cheng-Kung University, Taiwan
  • Director General, Center for Disease Control. (CDC), Taiwan
  • Professor and Chairman, Department of Pathology, National Cheng Kung University Hospital Medical School, Taiwan
  • Director, Institutes of Molecular Medicine and Clinical Medicine, National Cheng-Kung University Medical School, Taiwan
  • Professor and Chairman, Department and Institute of Pathology, National Taiwan University Medical College and Hospital, Taiwan
  • President, Taiwan Society of Pathology, Taiwan
  • Fellow Member, International Lymphoma Study Group
  • Scientific Consultant, CDC (Center for Disease Control), Department of Health, Taiwan

    RESEARCH INTERESTS

    Dr. Su's major research interest is on the pathogenesis and targeted therapy of virus-associated malignancies, including EBV-associated T cell lymphoma and hemophagocytic syndrome and HBV-related hepatocellutar carcinoma. In the past 20 years, he identified that EBV can infect T cells and cause T cell lymphoma and hemophago-cytic syndrome. His team clarified the signal pathway and target for therapy. Recently, they identified the HBV pre-S mutants as the potential oncoproteins through the ER stress signals. By identifying the specific signal pathway, they are now applying PPAR agonists and NFkB inhibitors for the prevention and therapy of these virus-associated immune disorders and human cancers.

    RESEARCH ACTIVITIES & ACCOMPLISHMENTS

    Dr. Su's laboratory is the leading group in the study of EVB-associated T cell lymphoma and hemophagocytic syndrome in the world. They first identified KSHV / HHV-8 in non-AIDS Kaposi's sarcoma. Their group also first identified HBV pre-S mutants in ground glass hepatocytes and clarified the biologic significance and its potential role in hepatocarcinogenesis. He has published a total of more than 200 papers in the journals like Lancet, Blood, Journal of Clinical Investigation, and Am. J. Pathol. During the SARS period, he served as the Director General of Taiwan CDC. He also coordinates the task force for infectious diseases like influenza, enteroviruses, HIV, and tuberculosis.

    HONORS & AWARDS

  • Ho Chi Ming Award, Vietnam, 2006
  • Associate Editor, Cancer Science, 2005-present
  • Distinguished Research Award (1991,1995, 1997); Special Appointed Award ( 2002, 2005), National Science Council, Taiwan
  • First Class Health Award (SARS Control), Department of Health, 2005
  • Lai Ho Award in medical service, 2000
  • Outstanding Award in Cancer Research, Dr. Hsu Chien-tien's Foundation
  • Fellow member, International Lymphoma Study Group, 1997-present
  • Ten Outstanding Young Person (TOYP) Award, 1990

    SELECTED PUBLICATIONS

    1.Chuang HC, Lay JD, Hsieh WC, Chang Y and Su IJ. EBV LMP-1 downregulates TNFR1 and confers resistance to TNF-a-induced apoptosis in T cells. Am J Pathol, 170;1607-1617, 2007.
    2.Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, Su IJ. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome. Blood, 106(9):3090-6, 2005.
    3.Wang HC, Chang WT, Chang WW, Lei HY, Lay MD and Su IJ. Hepatits B Virus pre-S2 mutant upregulates cyclin A and induces nodular proliferation of hepatocytes. Hepatology, 41:761-770, 2005.
    4.Ho MS, Su IJ: Preparing to prevent severe acute respiratory syndrome and other respiratory infections. Lancet (Infections Disease), 4 : 684-689, 2004.
    5.Wang HC, Wu HC, Chen CF, Lei HY, Su IJ. Different types of ground glass hepatocytes in chronic HBV infection centain specific pre-S mutants that may induce ER stress. Am J Pathol, 163: 2441-2449, 2003.
    		•